EMEA-001172-PIP01-11 - paediatric investigation plan

brinzolamide
brimonidine tartrate
PIPHuman

Key facts

Active Substance
  • brinzolamide
  • brimonidine tartrate
Therapeutic area
Ophthalmology
Decision number
P/259/2011
PIP number
EMEA-001172-PIP01-11
Pharmaceutical form(s)
  • Eye drops, solution
  • Suspension
Condition(s) / indication(s)
Treatment of glaucoma
Route(s) of administration
Ocular use
Contact for public enquiries

Alcon Laboratories (UK) Ltd.

Doug.MacHatton@AlconLabs.com
United States
Phone: +1 8175518974
Fax: +1 8176154607

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

Share this page